Fotios Plakogiannis
Fondatore presso Transdermal Research Pharm Laboratories LLC
Posizioni attive di Fotios Plakogiannis
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| Transdermal Research Pharm Laboratories LLC | Fondatore | 01/01/2013 | - |
| Presidente | 01/01/2013 | - | |
ChemioCare, Inc.
 ChemioCare, Inc. Pharmaceuticals: MajorHealth Technology ChemioCare, Inc. engages in the development and manufacture of pharmaceutical products. The company was founded in 2017 and is headquartered in New York, NY. | Direttore/Membro del Consiglio | - | - |
Starton Therapeutics, Inc.
 Starton Therapeutics, Inc. BiotechnologyHealth Technology Starton Therapeutics, Inc. is a clinical-stage biotechnology platform company that focuses on transforming standard of care therapies with proprietary continuous delivery technology. The company is based in Paramus, NJ. The company's goal is to provide continuous treatment to people with cancer so they can live better and longer. Starton's proprietary transdermal technology is intended to increase the efficacy of approved drugs, make them more tolerable, and expand their potential use. The company was founded in 2017 by Pedro Lichtinger, who has been the CEO since 2017. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Fotios Plakogiannis
Precedenti posizioni note di Fotios Plakogiannis
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| AEQUUS PHARMACEUTICALS INC. | Direttore/Membro del Consiglio | 03/01/2014 | 10/07/2018 |
| Presidente | 25/02/2013 | 10/12/2014 | |
| Fondatore | 03/01/2013 | 10/07/2018 | |
| Long Island University | Corporate Officer/Principal | 01/01/1967 | 01/01/2011 |
| Arnold & Marie Schwartz College of Pharmacy & Health Science | Corporate Officer/Principal | - | - |
Formazione di Fotios Plakogiannis
| University of Southern California | Doctorate Degree |
| The Ohio State University | Graduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 8 |
| Canada | 2 |
Posizioni
| Director/Board Member | 4 |
| Founder | 2 |
| Corporate Officer/Principal | 2 |
Settori
| Consumer Services | 5 |
| Health Technology | 4 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| AEQUUS PHARMACEUTICALS INC. | Health Technology |
| Aziende private | 3 |
|---|---|
ChemioCare, Inc.
ChemioCare, Inc. Pharmaceuticals: MajorHealth Technology ChemioCare, Inc. engages in the development and manufacture of pharmaceutical products. The company was founded in 2017 and is headquartered in New York, NY. | Health Technology |
Starton Therapeutics, Inc.
Starton Therapeutics, Inc. BiotechnologyHealth Technology Starton Therapeutics, Inc. is a clinical-stage biotechnology platform company that focuses on transforming standard of care therapies with proprietary continuous delivery technology. The company is based in Paramus, NJ. The company's goal is to provide continuous treatment to people with cancer so they can live better and longer. Starton's proprietary transdermal technology is intended to increase the efficacy of approved drugs, make them more tolerable, and expand their potential use. The company was founded in 2017 by Pedro Lichtinger, who has been the CEO since 2017. | Health Technology |
| Transdermal Research Pharm Laboratories LLC |
- Borsa valori
- Insiders
- Fotios Plakogiannis
- Esperienza
